SN

Suraj Naskar

Active Director Director DIN 07319931
DIN 07319931 First appointment May 2016 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Suraj Naskar

Data last updated:

Suraj Naskar is a Director at Ephesians Biotech Private Limited (since 2016). The company operates in Chemicals.

DIN 07319931
Primary Designation Director
Industry Chemicals
First Appointment 20 May 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ephesians Biotech Private Limited U24230DL2016PTC300089
Director20 May 20162016Active

Board colleagues of Suraj Naskar

Directorship timeline

Open interactive timeline →
Ephesians Biotech Private Limited
Premium access

Shareholding and investment profile for Suraj Naskar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suraj Naskar

Suraj Naskar currently holds 1 directorship: Ephesians Biotech Private Limited (Director, since 20 May 2016).

Suraj Naskar was first appointed on 20 May 2016 as Director at Ephesians Biotech Private Limited.

The current boards of Suraj Naskar's companies include Rajiv Kumar Jha (Ephesians Biotech Private Limited), Soumen Paul (Ephesians Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available